Aligos Therapeutics, Inc.
OXINDOLES AND METHODS OF USE THEREOF
Last updated:
Abstract:
Disclosed herein are compounds of Formula I': ##STR00001## or a stereoisomer or a tautomer thereof, or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising such compounds, and methods of treating disease by administering or contacting a subject with one or more of the above compounds.
Status:
Application
Type:
Utility
Filling date:
5 Nov 2021
Issue date:
12 May 2022